The objective of this guideline is to provide clinicians with evidence-based information about commonly used and available hysteroscopic distending media to guide them in their performance of both diagnostic and operative hysteroscopy. While necessary for the performance of hysteroscopy and hysteroscopically-directed procedures, distending media, if absorbed systemically in sufficient amounts, can have associated adverse events, including life-threatening complications. Consequently, understanding the physical properties and the potential risks associated with the use of the various distending media is critical for the safe performance of hysteroscopic procedures. This report was developed under the direction of the Practice Committee of the AAGL as a service to their members and other practicing clinicians.
Carbon Dioxide , Dextrans , Hysteroscopy/methods , Mannitol , Sorbitol , Dextrans/adverse effects , Dextrans/pharmacokinetics , Electrolytes , Female , Humans , Isotonic Solutions , Mannitol/adverse effects , Mannitol/pharmacokinetics , Sorbitol/adverse effects , Sorbitol/pharmacokinetics , Viscosity
